Management Team

Shawn P. McCarthy
President and CEO

Mr. McCarthy has over 20 years of experience in medical devices, including more than a decade with Cordis, Johnson & Johnson.

He held a variety of sales and marketing management roles with increasing responsibility, leading to the Worldwide Vice President of Marketing for the Cardiology, Endovascular, and Neurovascular business units.

Most recently, Mr. McCarthy was the SVP and General Manager for AngioDynamics, leading the company’s Vascular and Oncology Surgery business units.

He earned both his B.A. in Economics and M.B.A from Syracuse University.

Aaron V. Kaplan
M.D., F.A.C.C., F.S.C.A.I.

Dr. Aaron V. Kaplan is Professor of Medicine and of Community & Family Medicine and Director, Dartmouth Device Development Symposia at Dartmouth Medical School and Director of Research, Cardiac Catheterization Laboratories at the Dartmouth-Hitchcock Medical Center in Lebanon, N.H.

In addition to his clinical responsibilities, Dr. Kaplan supervises cardiology fellows, chairs the Dartmouth Device Development Symposia and lectures regularly at the Tuck School. Prior to joining the Dartmouth Faculty, Dr. Kaplan was director of Interventional Cardiology at the Palo Alto VA and served on the faculty at Stanford. Dr. Kaplan has more than 40 publications and is on the editorial board of Cardiac Catheterization and Intervention.

Dr. Kaplan has been an active medical device entrepreneur for more than 15 years and has been on the founding team of a number of venture-backed medical device companies including LocalMed and Perclose. In addition, Dr. Kaplan has consulted to NMT Medical, Guidant Corporation, Johnson & Johnson and was an Entrepreneur-In-Residence at Three Arch Partners. Dr. Kaplan has authored 18 U.S. Patents.

He received a B.S. from Tufts University, M.D. at Wake Forest University, medical training at Northwestern University and cardiology training at Stanford University.

H. Richard Davis
Chief Operating Officer

Richard Davis is an innovator and business professional who has invented and launched several novel medical device products while creating the supporting business infrastructure. Leveraging over 20 years of medical device experience during which he strategically innovated and managed intellectual property. As a business leader he has established clinical and marketing pathways, quality systems, supplier networks, and operations to foster rapid development of new products.

Prior to joining Tryton, Richard held positions at Cordis, a Johnson & Johnson company, and was one of the co-founders of OrbusNeich. While at Cordis he let a team of specialists from clinical research, regulatory affairs, product development and manufacturing for the development of novel coronary and peripheral stents.

In addition, during his tenure there he was responsible for transferring technology from plants in New Jersey and Miami to the Netherlands. During his eight years at OrbusNeich, Richard was instrumental to all aspects of the company’s development. He founded and directed the company’s European operations, including the design and formation of manufacturing facilities, sales and marketing, regulatory affairs, and clinical research groups.

Richard holds an M.S. in Mechanical Engineering from the Florida International University. Richard is co-author on numerous peer-reviewed publications in the field of coronary intervention and holds over 10 patents in the area of intravascular medical devices.

Brett Farabaugh
Chief Financial Officer

Brett Farabaugh has a diverse background working with entrepreneurial companies in the public and private arenas. Prior to Tryton Medical, Brett held the position of chief financial officer for StrikeIron, Inc., a venture-backed web-based data delivery company.

Prior to StrikeIron, Brett served as chief financial officer of Icoria, Inc. (formerly Paradigm Genetics, Inc.), a publicly traded biotech company acquired by Clinical Data, Inc. in 2005. Brett also held the role of vice president of finance for Nuada Pharmaceuticals, Inc.

Prior to joining Nuada Pharmaceuticals, he served for 12 years in various positions at PricewaterhouseCoopers (PwC), most recently as senior manager of the global technology industry group.

Brett’s experience includes financial management, analysis and reporting, initial public offerings and other exit strategies, extensive due diligence related to investment and acquisitions and fundraising in both the public and private markets.

He earned his degree in Accounting from the University of Virginia.

Douglas Ferguson
Vice President, Regulatory and Quality

Douglas Ferguson has more than 20 years of medical device experience, working in the areas of regulatory and clinical affairs, compliance, research and development, and quality assurance.

Douglas has brought a wide variety of products from early development to commercialization via simple and complex regulatory/clinical pathways to gain worldwide regulatory approvals.

Prior to joining Tryton, Douglas held positions at Becton Dickinson and Company, Boston Scientific Corporation, and C.R. Bard, Inc. While at Boston Scientific Corporation, Douglas spearheaded the effort to bring the company’s first drug eluting stent to worldwide markets, starting at the time of the first-in-man trial and serving as the principal liaison with the FDA and European notified body in obtaining approvals for this combination product.

He also played a significant role in finalizing the company’s overall approach to creating global regulatory/clinical strategies, incorporating risk identification and minimization to facilitate timely approvals.

Douglas holds a B.S. degree in Biomedical Engineering from the Johns Hopkins University and an M.S. degree in Biomedical Engineering from the University of Alabama at Birmingham.

Linda (Linn) Laak
BSN, Vice President Clinical

Linda (Linn) Laak’s 26 years of professional experience in the Medical device field includes 20 years in Clinical and Regulatory Affairs. She most recently held the position of Vice President of Regulatory, Clinical and QA for Atritech, Inc.

Linn has held positions of Executive Director PPD Medical Device following the sale of Eminent Research Systems and Clinsights Inc., where she was C.O.O and Vice President. Her experience includes positions of Vice President of Regulatory, Clinical and QA at XRT, C.L. MacIntosh & Ass., and Director of SCIMED’s Clinical Research Department where she worked in the marketing department as Group Product Manager of SCIMED’s Fixed Wire and Specialty Division.

Prior to working at SCIMED, Linn also worked with Pharmacia Deltec and AVI/3M Healthcare in various sales, marketing leadership positions.

Linn’s expertise in clinical studies, and regulatory and as well as her ability to successfully expedite the complicated process of getting product through clinical trials and to the market is some of her marked achievements in the Medical Device field.

She is also active in community volunteer activities with Catholic Women at Work and Groves Academy.

Michael Healy
QA/QC Director

Michael Healy has more than 30 years of medical device experience encompassing development, manufacturing, distribution and quality. Throughout his career he has implemented several FDA and ISO compliant quality systems for manufacturers of Class I, II and III medical devices.

Prior to joining Tryton, Michael held positions at Marquette Medical, GE Medical, Hill-Rom, Cook Endoscopy, Teleflex and provided Quality System consulting to Boston Scientific Corporation. During his time with these medical device companies Michael held responsibility for all aspects of the quality system and functioned as the Management Representative. Michael has been instrumental at resolving FDA and ISO issues at these companies.

He earned his degree in electrical engineering from Charter Oak State College in Connecticut. Additionally he holds Six Sigma certification from GE Medical along with Manager of Quality/Organizational Excellence certification and Quality Auditor certification from American Society for Quality (ASQ).